ASX - By Stock
|
PYC |
Re:
Ann: Phelan-McDermid Syndrome & CNS platform presentation
|
|
Biosurges
|
29 |
12K |
11 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
29
|
12K
|
11
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Biosurges
|
9.3K |
2.9M |
21 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
9.3K
|
2.9M
|
21
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Biosurges
|
9.3K |
2.9M |
14 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
9.3K
|
2.9M
|
14
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Biosurges
|
9.3K |
2.9M |
10 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
9.3K
|
2.9M
|
10
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Company Presentation
|
|
Biosurges
|
264 |
104K |
43 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
264
|
104K
|
43
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Ceasing to be a substantial holder
|
|
Biosurges
|
5 |
2.8K |
2 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
5
|
2.8K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Company Presentation
|
|
Biosurges
|
264 |
104K |
17 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
264
|
104K
|
17
|
|
ASX - By Stock
|
PYC |
Re:
PYC turns 2 corners
|
|
Biosurges
|
44 |
19K |
5 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
44
|
19K
|
5
|
|
ASX - By Stock
|
ADO |
Re:
NEW Anteotech website
|
|
Biosurges
|
101 |
29K |
15 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
101
|
29K
|
15
|
|
ASX - By Stock
|
PYC |
Re:
PYC turns 2 corners
|
|
Biosurges
|
44 |
19K |
7 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
44
|
19K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Trading Halt
|
|
Biosurges
|
30 |
10K |
12 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
30
|
10K
|
12
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Trading Halt
|
|
Biosurges
|
30 |
10K |
13 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
30
|
10K
|
13
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Changes to Leadership Team
|
|
Biosurges
|
92 |
36K |
39 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
92
|
36K
|
39
|
|
ASX - By Stock
|
ADO |
Re:
Shooting the breeze on ADO
|
|
Biosurges
|
5.6K |
1.6M |
35 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
5.6K
|
1.6M
|
35
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Trading Halt
|
|
Biosurges
|
16 |
8.2K |
28 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
16
|
8.2K
|
28
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech signs Non-Binding MOU with Wyon
|
|
Biosurges
|
135 |
48K |
41 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
135
|
48K
|
41
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Half Yearly Report and Accounts
|
|
Biosurges
|
21 |
7.1K |
10 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
21
|
7.1K
|
10
|
|
ASX - By Stock
|
ADO |
Re:
NON DILUTIVE GOV'T FUNDING
|
|
Biosurges
|
337 |
128K |
12 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
337
|
128K
|
12
|
|
ASX - By Stock
|
ADO |
Re:
NON DILUTIVE GOV'T FUNDING
|
|
Biosurges
|
337 |
128K |
9 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
337
|
128K
|
9
|
|
ASX - By Stock
|
ADO |
Re:
NON DILUTIVE GOV'T FUNDING
|
|
Biosurges
|
337 |
128K |
8 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
337
|
128K
|
8
|
|
ASX - By Stock
|
ADO |
Re:
Shooting the breeze on ADO
|
|
Biosurges
|
5.6K |
1.6M |
18 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
5.6K
|
1.6M
|
18
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Biosurges
|
9.3K |
2.9M |
30 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
9.3K
|
2.9M
|
30
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Company Update
|
|
Biosurges
|
75 |
29K |
13 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
75
|
29K
|
13
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech signs MOU with Trinseo
|
|
Biosurges
|
202 |
75K |
23 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
202
|
75K
|
23
|
|
ASX - By Stock
|
ADO |
Re:
Shooting the breeze on ADO
|
|
Biosurges
|
5.6K |
1.6M |
14 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
5.6K
|
1.6M
|
14
|
|
ASX - By Stock
|
PYC |
Re:
The Attractions of PYC's pipeline
|
|
Biosurges
|
38 |
17K |
9 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
38
|
17K
|
9
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Appointment of Chief Marketing Officer
|
|
Biosurges
|
33 |
11K |
32 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
33
|
11K
|
32
|
|
ASX - By Stock
|
PYC |
Re:
The Attractions of PYC's pipeline
|
|
Biosurges
|
38 |
17K |
3 |
11/02/23 |
11/02/23 |
ASX - By Stock
|
38
|
17K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Shooting the breeze on ADO
|
|
Biosurges
|
5.6K |
1.6M |
19 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
5.6K
|
1.6M
|
19
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Biosurges
|
9.3K |
2.9M |
5 |
05/02/23 |
05/02/23 |
ASX - By Stock
|
9.3K
|
2.9M
|
5
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Biosurges
|
9.3K |
2.9M |
28 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
9.3K
|
2.9M
|
28
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PYC Corporate Presentation - February 2023
|
|
Biosurges
|
15 |
6.7K |
10 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
15
|
6.7K
|
10
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Biosurges
|
288 |
84K |
7 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
288
|
84K
|
7
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Biosurges
|
288 |
84K |
6 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
288
|
84K
|
6
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Biosurges
|
288 |
84K |
13 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
288
|
84K
|
13
|
|
ASX - By Stock
|
ASM |
Re:
ASM Chart Thread
|
|
Biosurges
|
11K |
4.4M |
13 |
26/01/23 |
26/01/23 |
ASX - By Stock
|
11K
|
4.4M
|
13
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Biosurges
|
288 |
84K |
17 |
26/01/23 |
26/01/23 |
ASX - By Stock
|
288
|
84K
|
17
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful Toxicology Studies Pave Way for Human Trials
|
|
Biosurges
|
99 |
45K |
18 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
99
|
45K
|
18
|
|
ASX - By Stock
|
ADO |
Re:
2023 - The Year of ADO !
|
|
Biosurges
|
239 |
87K |
15 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
239
|
87K
|
15
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Biosurges
|
8 |
3.4K |
3 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
8
|
3.4K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Biosurges
|
9.3K |
2.9M |
18 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
9.3K
|
2.9M
|
18
|
|
ASX - By Stock
|
ASM |
Re:
ASM Chart Thread
|
|
Biosurges
|
11K |
4.4M |
2 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
11K
|
4.4M
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful Toxicology Studies Pave Way for Human Trials
|
|
Biosurges
|
99 |
45K |
6 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
99
|
45K
|
6
|
|
ASX - By Stock
|
ASM |
Re:
ASM Chart Thread
|
|
Biosurges
|
11K |
4.4M |
4 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
11K
|
4.4M
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful Toxicology Studies Pave Way for Human Trials
|
|
Biosurges
|
99 |
45K |
0 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
99
|
45K
|
0
|
|
ASX - By Stock
|
ASM |
Re:
Relevant Media
|
|
Biosurges
|
3.5K |
1.3M |
12 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
3.5K
|
1.3M
|
12
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful Toxicology Studies Pave Way for Human Trials
|
|
Biosurges
|
99 |
45K |
5 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
99
|
45K
|
5
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Biosurges
|
9.3K |
2.9M |
10 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
9.3K
|
2.9M
|
10
|
|
ASX - By Stock
|
ASM |
Re:
Ann: Update to timing of NdPr metal sale and delivery to NS World
|
|
Biosurges
|
90 |
38K |
6 |
28/12/22 |
28/12/22 |
ASX - By Stock
|
90
|
38K
|
6
|
|
ASX - By Stock
|
ASM |
Re:
Ann: Update to timing of NdPr metal sale and delivery to NS World
|
|
Biosurges
|
90 |
38K |
6 |
28/12/22 |
28/12/22 |
ASX - By Stock
|
90
|
38K
|
6
|
|